论文部分内容阅读
A new Schiff base compound (I), (E)-N’-(2-hydroxy-3-methoxybenzylidene)-3,4-dihydroxybenzohydrazide-ethanol-water (1/1/1), has been synthesized and characterized by elemental analysis, IR spectra, and single-crystal X-ray diffraction. The crystal belongs to monoclinic, space group P21/n with a = 7.459(4), b = 18.316(10), c = 13.638(7), β = 101.585(9)o, V = 1825.2(17)3, Z = 4, μ = 0.104 mm-1, Dc = 1.333 g/cm3, F(000) = 776, the final R = 0.0635 and wR = 0.1302 for 3216 observed reflections with I > 2σ(I). Another compound (Ⅱ), (E)-N’-(2,5-dimethoxybenzylidene)-3,4-dihydroxybenzohydrazide-ethanol-water (1/1/1), has been synthesized and reported before. The antibacterial activities of these two compounds against seven bacteria were first evaluated, and one compound showed considerable antibacterial activity against S. aureus.
A new Schiff base compound (I), (2-hydroxy-3-methoxybenzylidene) -3,4-dihydroxybenzohydrazide- ethanol-water (1/1/1), has been synthesized and characterized by elemental The crystal belongs to monoclinic, space group P21 / n with a = 7.459 (4), b = 18.316 (10), c = 13.638 101.585 (9) o, V = 1825.2 (17) 3, Z = 4, μ = 0.104 mm-1, Dc = 1.333 g / cm3, F (000) = 776, the final R = 0.0635 and wR = 0.1302 for Another compound (II), (E) -N ’- (2,5-dimethoxybenzylidene) -3,4-dihydroxybenzohydrazide- ethanol-water (1/1/1), has been synthesized and reported before. The antibacterial activities of these two compounds were seven bacteria were first evaluated, and one compound was considerable antibacterial activity against S. aureus.